Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of remimazolam toluenesulfonate for gastroscopy sedation in elderly patients
ChiCTR2100053463Phase 4Recruiting
- Sponsor
- Quanzhou First Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in None (3 arms), sponsored by Quanzhou First Hospital. Primary endpoints: Anesthetic effect and Systolic blood pressure, diastolic blood pressure, heart rate, and oxygen saturation. Started Dec 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100053463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053463.